Prophylactic Antiemetic Therapy with Patient-Controlled Analgesia

Publisher Website
Google Scholar
Abstract
This placebo-controlled, randomized, double-blind trial was designed to evaluate the efficacy of three prophylactic antiemetic regimens on postoperative nausea and vomiting (PONV) during patient-controlled analgesia (PCA) with morphine. We studied 286 elective surgical patients for 36 h postoperatively. Group 1 was saline control. In Groups 2 and 3, metoclopramide or droperidol was administered as an intravenous (IV) bolus and then added to morphine in the PCA device. In Group 4, tropisetron, a long-acting investigational 5-hydroxytryptamine subtype 3 (5-HT3) antagonist was given as a single IV dose. We assessed the frequency and severity of PONV, as well as the need for rescue, frequency of side effects, and overall patient satisfaction. Severity of PONV was measured with a symptom-severity score (STS) which was based on both intensity and duration. The average total doses of antiemetics were metoclopramide 53.8 ± 2.2 mg, droperidol 5.99 ± 0.3 mg, and tropisetron 6.1 ± 0.2 mg. Control patients had a 54% incidence of PONV. Droperidol reduced both the incidence (P

This publication has 0 references indexed in Scilit: